Published in Exp Parasitol on November 01, 1996
Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand CD200. Cell Host Microbe (2011) 1.59
Priming of a beta-galactosidase (beta-GAL)-specific type 1 response in BALB/c mice infected with beta-GAL-transfected Leishmania major. Infect Immun (2000) 0.83
An in vitro model for infection with Leishmania major that mimics the immune response in mice. Infect Immun (1997) 0.83
Topical resiquimod protects against visceral infection with Leishmania infantum chagasi in mice. Clin Vaccine Immunol (2014) 0.76
A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol (1985) 4.71
Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J Immunol (1985) 3.47
Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA. J Am Chem Soc (2001) 2.55
Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity. J Immunol (1984) 2.35
APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A (1996) 2.18
Regulation of differentiation to the infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin. Science (2001) 1.77
Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection. J Immunol (2001) 1.74
A simple method for quantifying Leishmania in tissues of infected animals. Parasitol Today (1997) 1.61
An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorferi B31. Infect Immun (1999) 1.60
Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet (1999) 1.57
Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution. Infect Immun (1990) 1.55
Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon. Clin Exp Immunol (1984) 1.51
Outbreak of tuberculosis in a migrants' shelter, Paris, France, 2002. Int J Tuberc Lung Dis (2005) 1.50
Orally induced tolerance. Definition at the cellular level. Int Arch Allergy Appl Immunol (1981) 1.48
Analysis of enhancing effect of sand fly saliva on Leishmania infection in mice. Infect Immun (1991) 1.46
Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice. J Immunol (1986) 1.45
Experimental syphilis in the rabbit: passive transfer of immunity with immunoglobulin G from immune serum. J Infect Dis (1979) 1.44
Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing. J Immunol (1991) 1.43
The immunomodulatory factors of bloodfeeding arthropod saliva. Parasite Immunol (2000) 1.42
Saliva of the Lyme disease vector, Ixodes dammini, blocks cell activation by a nonprostaglandin E2-dependent mechanism. J Exp Med (1994) 1.39
Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice. Infect Immun (1996) 1.32
Saliva of Lutzomyia longipalpis sibling species differs in its composition and capacity to enhance leishmaniasis. Philos Trans R Soc Lond B Biol Sci (1994) 1.29
Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production. J Immunol (1995) 1.28
Hemispheric disconnection syndrome with a "crossed avoiding" reaction in a case of Marchiafava-Bignami disease. J Neurol Neurosurg Psychiatry (1977) 1.27
Identification of an IL-2 binding protein in the saliva of the Lyme disease vector tick, Ixodes scapularis. J Immunol (2001) 1.21
[Letter: Toxic polyneuritis in a plastic worker. Possible role of methyl-ethyl-ketone]. Nouv Presse Med (1975) 1.20
Salivary gland material from the sand fly Lutzomyia longipalpis has an inhibitory effect on macrophage function in vitro. Parasite Immunol (1993) 1.19
Variation in the salivary peptide, maxadilan, from species in the Lutzomyia longipalpis complex. Insect Mol Biol (1999) 1.19
Peptides encoded by the calcitonin gene inhibit macrophage function. J Immunol (1989) 1.19
Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major. J Immunol (1998) 1.18
Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11q12-13. J Bone Miner Res (1998) 1.18
Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response. J Infect Dis (1996) 1.14
Variants with reduced virulence derived from Leishmania major after mutagen treatment. Parasite Immunol (1987) 1.12
Analysis of the immune responses of mice to infection with Leishmania braziliensis. Infect Immun (1998) 1.11
Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes. Infect Immun (1997) 1.11
Leishmania major-parasitized macrophages augment Th2-type T cell activation. J Immunol (1994) 1.11
A simple and effective method to assess murine delayed type hypersensitivity to proteins. J Immunol Methods (1981) 1.11
Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo. Infect Immun (1991) 1.10
Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme. Oncogene (2012) 1.04
Transcription of the tumor necrosis factor alpha gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin A and FK506 in human B cells. Proc Natl Acad Sci U S A (1992) 1.03
Histologic characterization of experimental cutaneous leishmaniasis in mice infected with Leishmania braziliensis in the presence or absence of sand fly vector salivary gland lysate. J Parasitol (1998) 1.01
T cell and non-T cell compartments can independently determine resistance to Leishmania major. J Exp Med (1995) 1.00
Colonization and disinfection of biofilms hosting coliform-colonized carbon fines. Appl Environ Microbiol (1996) 0.99
Leishmania major-specific, CD4+, major histocompatibility complex class II-restricted T cells derived in vitro from lymphoid tissues of naive mice. J Exp Med (1993) 0.98
New insights into p53 function from structural studies. Oncogene (1996) 0.97
Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the disease. J Infect Dis (1995) 0.96
Cellular immune responses to mycobacteria in healthy and human immunodeficiency virus-positive subjects in the United States after a five-dose schedule of Mycobacterium vaccae vaccine. Clin Infect Dis (1998) 0.95
The effect of treating with anti-interleukin-1 receptor antibody on the course of experimental murine cutaneous leishmaniasis. Parasite Immunol (1994) 0.95
An avirulent lipophosphoglycan-deficient Leishmania major clone induces CD4+ T cells which protect susceptible BALB/c mice against infection with virulent L. major. Infect Immun (1993) 0.94
Physical properties of pizza Mozzarella cheese manufactured under different cheese-making conditions. J Dairy Sci (2013) 0.94
Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major. Parasite Immunol (1999) 0.91
Evaluation of a recombinant parasite antigen for the diagnosis of lymphatic filariasis. Am J Trop Med Hyg (1994) 0.89
Reversion to virulence in Leishmania major correlates with expression of surface lipophosphoglycan. Mol Biochem Parasitol (1993) 0.89
Interactions of yeast valyl-tRNA synthetase with RNAs and conformational changes of the enzyme. J Mol Biol (1979) 0.89
[Familial parkinsonian syndrome with athymhormia and hypoventilation]. Rev Neurol (Paris) (1992) 0.88
[Neurologic forms of Lyme disease. 12 cases]. Rev Neurol (Paris) (1989) 0.88
Electrophoresis PDMS/glass chips with continuous on-chip derivatization and analysis of amino acids using naphthalene-2,3-dicarboxaldehyde as fluorogenic agent. Anal Chim Acta (2008) 0.88
Expression and tyrosine phosphorylation of the T cell receptor zeta-subunit in human thymocytes. J Immunol (1991) 0.87
[The coxopodopatellar syndrome]. J Radiol (1985) 0.87
Virulent or avirulent (dhfr-ts-) Leishmania major elicit predominantly a type-1 cytokine response by human cells in vitro. Clin Exp Immunol (2000) 0.87
The influence of antigen-presenting cell type and interferon-gamma on priming and cytokine secretion of Leishmania major-specific T cells. J Infect Dis (1997) 0.86
Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. J Immunol (1994) 0.86
Leishmania major: nature of immunity induced by immunization with a mutagenized avirulent clone of the parasite in mice. Exp Parasitol (1990) 0.85
Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women. J Clin Endocrinol Metab (2005) 0.85
A PET study of the functional neuroanatomy of writing impairment in Alzheimer's disease. The role of the left supramarginal and left angular gyri. Brain (1995) 0.85
Safety and immunogenicity of a five-dose series of inactivated Mycobacterium vaccae vaccination for the prevention of HIV-associated tuberculosis. Clin Infect Dis (2000) 0.84
The PACAP-type I receptor agonist maxadilan from sand fly saliva protects mice against lethal endotoxemia by a mechanism partially dependent on IL-10. Eur J Immunol (1998) 0.84
An in vitro model for infection with Leishmania major that mimics the immune response in mice. Infect Immun (1997) 0.83
Influence of costimulatory molecules on immune response to Leishmania major by human cells in vitro. Infect Immun (2001) 0.83
Priming of a beta-galactosidase (beta-GAL)-specific type 1 response in BALB/c mice infected with beta-GAL-transfected Leishmania major. Infect Immun (2000) 0.83
Interactions between a paramagnetic analogue of cholesterol and filipin. Biochim Biophys Acta (1988) 0.82
Rapid early onset lymphocyte cell death in mice resistant, but not susceptible to Leishmania major infection. Apoptosis (2000) 0.82
Resolution of an infection with Leishmania braziliensis confers complete protection to a subsequent challenge with Leishmania major in BALB/c mice. Mem Inst Oswaldo Cruz (1999) 0.81
Leishmania major induces differential expression of costimulatory molecules on mouse epidermal cells. Eur J Immunol (2001) 0.81
Right motor neglect associated with dynamic aphasia, loss of drive and amnesia: case report and cerebral blood flow study. Neuropsychologia (1992) 0.81
Major histocompatibility complex class II-independent generation of neutralizing antibodies against T-cell-dependent Borrelia burgdorferi antigens presented by dendritic cells: regulation by NK and gammadelta T cells. Infect Immun (2001) 0.81
Immunization of healthy adult subjects in the United States with inactivated Mycobacterium vaccae administered in a three-dose series. Clin Infect Dis (1997) 0.81
Investigation of NMR limits of detection for implantable microcoils. Conf Proc IEEE Eng Med Biol Soc (2007) 0.81
The influence of nickel on the adhesion ability of Desulfovibrio desulfuricans. Colloids Surf B Biointerfaces (2005) 0.81
Idiopathic avascular necrosis of the scaphoid: Preiser's disease? J Hand Surg Am (1989) 0.80
Abnormal sulfate metabolism in vitamin D-deficient rats. J Clin Invest (1997) 0.80
Conformational studies on muscular parvalbumins cooperative binding of calcium (II) to parvalbumins. Biochimie (1979) 0.80
A method for the isolation and analysis of leucocytic cells from Leishmanial ear lesions in mice. J Immunol Methods (1999) 0.79
Retracted Recombinant human migration inhibitory factor has adjuvant activity. Proc Natl Acad Sci U S A (1992) 0.79
A new paramagnetic analogue of cholesterol as a tool for studying molecular interactions of genuine cholesterol. Biochim Biophys Acta (1987) 0.79
Compositional and functional properties of buttermilk: a comparison between sweet, sour, and whey buttermilk. J Dairy Sci (2006) 0.79
A universal optical all-fiber Omnipolarizer. Sci Rep (2012) 0.79
[Delirium following heart surgery with extracorporeal circulation: clinical aspects and observations in a specialized center]. Can J Psychiatry (1982) 0.79
An oriented phase-II trial of D-Trp6-LH-RH in patients with prostatic carcinoma. Med Oncol Tumor Pharmacother (1984) 0.79
Identification of differentially regulated micrornas in cold-hardy insects. Cryo Letters (2013) 0.79
Observation of light-by-light polarization control and stabilization in optical fibre for telecommunication applications. Opt Express (2010) 0.78
Subsets of specific T cells and experimental cutaneous leishmaniasis. Ann Inst Pasteur Immunol (1988) 0.78
Interaction of Desulfovibrio desulfuricans biofilms with stainless steel surface and its impact on bacterial metabolism. J Appl Microbiol (2006) 0.78
Combined chemotherapy in the management of metastatic bladder cancer. Br J Urol (1981) 0.77
[Crying provoked by sound stimuli in a case of probable dementia of Alzheimer's type]. Rev Neurol (Paris) (1988) 0.77
Analysis of anti-HIV nucleoside inhibitors by capillary electrophoresis-electrospray ionization mass spectrometry. Nucleosides Nucleotides Nucleic Acids (2001) 0.77
Nuclear magnetic resonance study of cancer: systemic effect on the proton relaxation times (T1 and T2) of human serum. Cancer Detect Prev (1981) 0.77
Randomised trial of intradermal Mycobacterium vaccae or intradermal hepatitis B immunisation in children with HIV infection. Vaccine (1999) 0.77
Analysis of intracellular didanosine triphosphate at sub-ppb level using LC-MS/MS. J Pharm Biomed Anal (2001) 0.77